Kaldor Stephen W
Insider CIK 1507502 · FURX Director · CRNX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2020-06-19 | 2020-06-22 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CRNX Crinetics Pharmaceuticals, | A Award deriv | 2019-06-21 | 2019-06-25 | 12,500 | — | $0 | 12,500 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 5,012 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 8,825 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer deriv | 2014-07-02 | 2014-07-07 | 17,500 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | D To issuer | 2014-07-02 | 2014-07-07 | 7,160 | — | $0 | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award | 2014-02-28 | 2014-03-04 | 3,580 | — | $0 | 7,160 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award | 2013-05-24 | 2013-05-29 | 3,580 | — | $0 | 3,580 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2013-03-13 | 2013-03-14 | 1,648 | — | $0 | 5,012 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2013-03-13 | 2013-03-14 | 1,648 | $39.96 | $65.9K | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2013-03-13 | 2013-03-14 | 1,648 | $13.94 | $23.0K | 1,648 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2013-03-12 | 2013-03-14 | 973 | — | $0 | 6,660 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2013-03-12 | 2013-03-13 | 973 | $40.71 | $39.6K | 1,648 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2013-03-12 | 2013-03-14 | 973 | $13.94 | $13.6K | 973 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2013-03-12 | 2013-03-14 | 973 | $40.71 | $39.6K | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2013-03-11 | 2013-03-13 | 8,000 | — | $0 | 5,012 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise deriv | 2013-03-11 | 2013-03-14 | 5,379 | — | $0 | 7,633 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2013-03-11 | 2013-03-13 | 5,379 | $41.74 | $224.5K | 2,621 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2013-03-11 | 2013-03-13 | 8,000 | $13.94 | $111.5K | 8,000 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | M Exercise | 2013-03-11 | 2013-03-14 | 5,379 | $13.94 | $75.0K | 5,379 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | S Sale | 2013-03-11 | 2013-03-14 | 5,379 | $41.74 | $224.5K | 0 | SEC↗ |
| FURX Furiex Pharmaceuticals, In | A Award deriv | 2012-05-24 | 2012-05-29 | 17,500 | — | $0 | 17,500 | SEC↗ |